Interleukin 17a Antikörper
Kurzübersicht für Interleukin 17a Antikörper (ABIN6964028)
Target
Alle Interleukin 17a (IL17A) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Native and recombinant IL-17A.
-
Kreuzreaktivität (Details)
- The antibody cross-reacts with IL-17A from non-human primates. Cross-reactivity has been tested in ELISA and/or ELISpot.
-
Aufreinigung
- Purified from in vitro cultures by protein G affinity chromatography.
-
Immunogen
- Recombinant human IL-17A
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Neutralization of human IL-17A bioactivity. It is recommended to establish the optimal antibody concentration for the assay system used. The antibody is also suitable for immunoassays. Neutralization Neutralization assay: Neutralization of human IL-17A induced IL-6 production (see graph). To determine the neutralizing capacity and ND50, various concentrations of mAb MT504 and human recombinant IL-17A were added to normal human dermal fibroblasts. Following overnight incubation, cell supernatants were quantified in IL-6 ELISA. Neutralization dose 50 (ND50): MT504 neutralized the effect of IL-17A at a ND50value of 0.01-0.03 μg/mL when 10 ng/mL IL-17A was present. ND50 is defined as the concentration of antibody that results in 50 % inhibition of the biological response under the experimental conditions specified.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- supplied at 0.5 mg/mL in PBS free of preservatives
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/thawing.
-
Haltbarkeit
- 18 months
-
-
- Interleukin 17a (IL17A) (Interleukin 17A (IL17A))
-
Andere Bezeichnung
- IL17A
-
Gen-ID
- 3605
Target
-